Adolescent Lifestyle Medicine Headache Study
NCT07373275 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2026-05-06
Summary
The goal of this pilot clinical trial is to assess the implementation of a 7-week Lifestyle Medicine intervention for adolescents with headache. The main question it aims to answer is:
Is it feasible to implement a Lifestyle Medicine curriculum for adolescents with headache and secondarily, does this intervention show any signal for improving headache symptoms?
Participants will be divided into two groups based on the order of their enrollment. After consent, they will be asked to complete 3 symptom surveys: PedMIDAS-6w, PHQ-A and GAD-7, in addition to a Lifestyle Survey. They will attend group medicine visits virtually, facilitated by the study team. Each week will address a different tenant of Lifestyle Medicine (such as eating or sleep) and participants will create a SMART goal to work on for the week. At the end of the seven weeks, they will repeat these symptom and lifestyle surveys. During the seven weeks, they will also keep a daily symptom diary, which will be texted to their phones through a HIPPA-compliant RedCAP database.
Conditions
- Headache, Migraine
Interventions
- BEHAVIORAL
-
Lifestyle Medicine Group Medical Visits
Participants will attend a virtual, one-hour weekly lifestyle medicine group session with their peers for 7 weeks. Each session will address one pillar of Lifestyle Medicine: restorative sleep, healthy eating, stress management, physical activity, avoiding risky substances, and positive social connection. During each session, study team members will provide a short presentation of key components of that lifestyle intervention and meet with participants in small groups to discuss goals related to that pillar (i.e. eat 2 more vegetables a day for five days). During the course of these 7 weeks, participants will also keep a virtual daily headache journal; a link to this journal will be sent through an automated text with a HIPPA-compliant REDCap database. This will be sent daily at 5 pm.
Sponsors & Collaborators
-
MaineHealth
lead OTHER
Principal Investigators
-
Jennifer Dubail, M.D. · MaineHealth
-
Helis Jason, M.D. · MaineHealth
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 14 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-02-10
- Primary Completion
- 2027-03-31
- Completion
- 2027-12-31
Countries
- United States
Study Locations
More Related Trials
-
Melatonin for Adolescent Migraine Prevention Study
NCT03150797 ·Status: TERMINATED ·Phase: PHASE2
-
Pediatric Chronic Headache Trial
NCT00389038 ·Status: UNKNOWN ·Phase: PHASE3
-
BE WELL With Migraine: Brain Education and WELLness With Migraine
NCT05987592 ·Status: RECRUITING ·Phase: NA
-
Dietary Intervention for Migraine Relief
NCT07360405 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Melatonin for Migraine Prevention
NCT00849511 ·Status: COMPLETED ·Phase: PHASE2
-
An Intervention to Improve Adolescent Headache Self-management
NCT02475005 ·Status: COMPLETED ·Phase: NA
-
Smartphone Use Restriction as Treatment of Primary Headache
NCT06041997 ·Status: RECRUITING ·Phase: NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
NCT05415020 ·Status: RECRUITING ·Phase: NA
-
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
NCT04965675 ·Status: RECRUITING ·Phase: PHASE3
-
Educational Video Program to Promote Physical Activity and Reduce Migraine Frequency in Adults With Migraine
NCT06993545 ·Status: COMPLETED ·Phase: NA
-
Study of Treatment Used for Migraine Headaches (MK-0974-076)
NCT01421277 ·Status: TERMINATED
-
Facilitating Migraine Medication Adherence and Optimizing Medication Use
NCT02473692 ·Status: WITHDRAWN
-
Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents
NCT00963937 ·Status: COMPLETED ·Phase: PHASE3
-
Mindfulness-Based Intervention for Adolescents With Chronic Migraine
NCT06414109 ·Status: COMPLETED ·Phase: NA
-
A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine
NCT00109083 ·Status: COMPLETED ·Phase: PHASE2
-
MigraineManager: An Individualized Self-Management Tool for Adolescents With Migraine
NCT03157739 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Behavioral Insomnia Treatment for Chronic Migraine
NCT01314651 ·Status: COMPLETED ·Phase: NA
-
Bringing Relief to Adolescents Naturally Using Melatonin for Migraine
NCT02344316 ·Status: COMPLETED ·Phase: PHASE2
-
Coping Skills Training in Individuals With Migraine
NCT05809375 ·Status: UNKNOWN ·Phase: NA
-
Trial of Comprehensive Migraine Intervention
NCT01071317 ·Status: COMPLETED ·Phase: PHASE4
-
A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
NCT05133323 ·Status: COMPLETED ·Phase: PHASE2
-
Mind Body Balance for Pediatric Migraine
NCT04715685 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Efficacy and Safety of add-on Alpha-lipoic Acid on Migraine Prophylaxis in Adolescent Population
NCT04064814 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age
NCT04464707 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study Examining The Use Of Duloxetine In The Prevention Of Migraine Headache
NCT00443352 ·Status: COMPLETED ·Phase: PHASE4